European urology oncologySrivastava T, Prabhu VS, Li H, Xu R, Zarabi N, Zhong Y, Pellissier JM, Perini RF, de Wit R, Mamtani R.Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in SwedenUrothelial Carcinoma2018Journal ArticleDecision Modelling
5
by [email protected] | Oct 13, 2020